未登录 分享 收藏
分享 收藏
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®) Singh, Chandramani; Verma, Savita; Reddy, Prabhakar; Diamond, Michael S.; Curiel, David T.; Patel, Chintan; Jain, Manish Kumar; Redkar, Sagar Vivek; Bhate, Amit Suresh; Gundappa, Vivek; Konatham, Rambabu; Toppo, Leelabati; Joshi, Aniket Chandrakant; Kushwaha, Jitendra Singh; Singh, Ajit Pratap; Bawankule, Shilpa; Ella, Raches; Prasad, Sai; Ganneru, Brunda; Chiteti, Siddharth Reddy; Kataram, Sreenivas; Vadrevu, Krishna Mohan 分享 收藏
A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine Bansode, Sneha; Singh, Pawan Kumar; Tellis, Meenakshi; Chugh, Anita; Deshmukh, Narendra; Gupta, Mahesh; Verma, Savita; Giri, Ashok; Kulkarni, Mahesh; Joshi, Rakesh; Chaudhary, Dhruva 分享 收藏
分享 收藏
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants Vadrevu, Krishna Mohan; Ganneru, Brunda; Reddy, Siddharth; Jogdand, Harsh; Raju, Dugyala; Sapkal, Gajanan; Yadav, Pragya; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar Vivek; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Mohapatra, Satyajit; Bhate, Amit; Rai, Sanjay Kumar; Ella, Raches; Abraham, Priya; Prasad, Sai; Ella, Krishna 分享 收藏
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Ella, Raches; Reddy, Siddarth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay K.; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; Multani, Manish; Mohammad, Shameem; Bhatt, Parul; Kumari, Laxmi; Sapkal, Gajanan; Gupta, Nivedita; Abraham, Priya; Panda, Samiran; Prasad, Sai; Bhargava, Balram; Ella, Krishna; Vadrevu, Krishna Mohan 分享 收藏
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial Ella, Raches; Reddy, Siddharth; Jogdand, Harsh; Sarangi, Vamshi; Ganneru, Brunda; Prasad, Sai; Das, Dipankar; Raju, Dugyala; Praturi, Usha; Sapkal, Gajanan; Yadav, Pragya; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar Vivek; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Mohapatra, Satyajit; Bhate, Amit; Rai, Sanjay; Panda, Samiran; Abraham, Priya; Gupta, Nivedita; Ella, Krishna; Bhargava, Balram; Vadrevu, Krishna Mohan 分享 收藏
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial Ella, Raches; Vadrevu, Krishna Mohan; Jogdand, Harsh; Prasad, Sai; Reddy, Siddharth; Sarangi, Vamshi; Ganneru, Brunda; Sapkal, Gajanan; Yadav, Pragya; Abraham, Priya; Panda, Samiran; Gupta, Nivedita; Reddy, Prabhakar; Verma, Savita; Rai, Sanjay Kumar; Singh, Chandramani; Redkar, Sagar Vivek; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Mohapatra, Satyajit; Rao, Venkat; Guleria, Randeep; Ella, Krishna; Bhargava, Balram 分享 收藏
Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes Jacob, Neenu; Jaiswal, Shivani; Maheshwari, Deep; Nallabelli, Nayudu; Khatri, Neeraj; Bhatia, Alka; Bal, Amanjit; Malik, Vivek; Verma, Savita; Kumar, Rakesh; Sachdeva, Naresh 分享 收藏
A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213. Bernstein, V.; Ellard, S. L.; Dent, S. F.; Tu, D.; Mates, M.; Dhesy-Thind, S. K.; Panasci, L.; Gelmon, K. A.; Salim, M.; Song, X.; Clemons, M.; Ksienski, D.; Verma, S.; Simmons, C.; Lui, H.; Chi, K.; Feilotter, H.; Hagerman, L. J.; Seymour, L. 分享 收藏
分享 收藏
分享 收藏
A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200 Chu, Q. S. -C.; Nielsen, T. O.; Alcindor, T.; Gupta, A.; Endo, M.; Goytain, A.; Xu, H.; Verma, S.; Tozer, R.; Knowling, M.; Bramwell, V. B.; Powers, J.; Seymour, L. K.; Eisenhauer, E. A. 分享 收藏
分享 收藏
分享 收藏
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women Cigler, T.; Tu, D.; Yaffe, M. J.; Findlay, B.; Verma, S.; Johnston, D.; Richardson, H.; Hu, H.; Qi, S.; Goss, P. E. 分享 收藏
分享 收藏
分享 收藏
分享 收藏